PHAXIAM Therapeutics S.A.
PHXM · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11 | – | – | $1 |
| Dep. & Amort. | $0 | – | – | $2 |
| Deferred Tax | $0 | – | – | -$3 |
| Stock-Based Comp. | $0 | – | – | -$10 |
| Change in WC | -$2 | – | – | -$5 |
| Other Non-Cash | $1 | – | – | $5 |
| Operating Cash Flow | -$13 | – | – | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | – | – | -$0 |
| Net Acquisitions | $0 | – | – | $0 |
| Inv. Purchases | -$0 | – | – | $0 |
| Inv. Sales/Matur. | $0 | – | – | $0 |
| Other Inv. Act. | $0 | – | – | $0 |
| Investing Cash Flow | -$0 | – | – | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | – | $0 |
| Stock Issued | $0 | – | – | $0 |
| Stock Repurch. | $0 | – | – | $0 |
| Dividends Paid | $0 | – | – | $0 |
| Other Fin. Act. | -$2 | – | – | -$4 |
| Financing Cash Flow | -$2 | – | – | -$4 |
| Forex Effect | $0 | – | – | $0 |
| Net Chg. in Cash | $0 | – | – | -$15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25 | – | – | $53 |
| End Cash | $10 | – | – | $39 |
| Free Cash Flow | -$13 | – | – | -$11 |